Close mobile menu×
Close mobile menu

E. Yoko Furuya, MD, MS

Board Certifications: 
Infectious Disease
Not Accepting New Patients
Profile Headshot

Schedule an Appointment

Phone Appointments

New and Existing Patients:

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Connect Sign In

Credentials & Experience

Board Certifications

  • Infectious Disease

Clinical Expertise

  • Bacterial Infection
  • Epidemiology
  • Hospital Acquired Infections
  • Infectious Disease

Specialties

Education & Training

  • University of Pennsylvania School of Medicine
  • MS, Columbia University, Mailman School of Public Health
  • Residency: Hospital of the University of Pennsylvania
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

About E. Furuya

Dr. Yoko Furuya is a nationally recognized epidemiologist and specialist in infectious diseases, with 20 years of clinical experience. She is the Medical Director of Infection Prevention & Control and Director of Antibiotic Stewardship for all campuses of NewYork-Presbyterian Hospital (NYPH) including the university hospitals of Columbia and Cornell. She is also Associate Professor of Medicine at Columbia University Irving Medical Center in the Division of Infectious Diseases (ID).

Dr. Furuya graduated from Harvard University with a major in English literature. She then received her M.D. degree from the University of Pennsylvania School of Medicine, where she also underwent residency training in internal medicine. Subsequently, she moved to New York and completed additional training with a clinical fellowship in infectious diseases at Columbia University. During this time she received a Masters of Science degree in Epidemiology at the Mailman School of Public Health at Columbia University.

Since completing her medical and epidemiologic training, Dr. Furuya has become a leader in healthcare epidemiology both locally and nationally. She has published nearly 70 articles in the peer-reviewed literature and has served as an investigator on numerous NIH- , CDC-, and New York State Department of Health-funded studies looking at multidrug-resistant organisms, infection prevention and control practices, and costs of antimicrobial resistance. She served on the joint CDC/Society for Healthcare Epidemiology of America (SHEA) Outbreak Response Training Program advisory panel, establishing a national training program for healthcare epidemiologists on responding to pandemics and emerging infectious diseases. Based on her experience addressing outbreaks such as the 2009 H1N1 influenza pandemic, Ebola, and measles, she has been interviewed numerous times in print, radio, and TV including for CNN, CBS, NPR, and the New York Times, including most recently about the COVID-19 pandemic. In 2018, Dr. Furuya was honored for her achievements in the field of healthcare epidemiology by being recognized as a Fellow of the Society for Healthcare Epidemiology of America (SHEA).

Academic Titles

  • Associate Professor of Medicine at CUMC

Administrative Positions

  • Medical Director of Infection Control and Hospital Epidemiology, NewYork-Presbyterian Hospital
  • Director, Antimicrobial Stewardship for NewYork-Presbyterian Hospital

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

Affinity

  • Essential Plan
  • Medicaid Managed Care

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Amida Care

  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Elderplan

  • Medicare Managed Care

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Empire Blue Cross Blue Shield HealthPlus

  • Child/Family Health Plus
  • Essential Plan
  • Medicaid Managed Care

Fidelis Care

  • Child/Family Health Plus
  • Medicaid Managed Care
  • Medicare Managed Care

Healthfirst

  • Child/Family Health Plus
  • Leaf (Exchange)
  • Medicaid Managed Care
  • Medicare Managed Care

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Medicare

  • Traditional Medicare (NY)

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • Compass (Exchange)
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

VNSNY CHOICE

  • Medicare Managed Care
  • SelectHealth
  • Special Needs Plan

WellCare

  • Medicaid Managed Care
  • Medicare Managed Care

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
180 Fort Washington Avenue
Suite 242
New York, New York 10032
Primary

Research

Dr. E. Yoko Furuya's research interests are focused in the areas of hospital epidemiology and antimicrobial resistance. She is a co-investigator on numerous NIH- and CDC-funded grants on topics such as multidrug-resistant gram-negative bacilli, the financial costs of healthcare-associated infections and antimicrobial resistance, and the impact of an automated infection control surveillance system on isolation precautions for/transmission of methicillin-resistant Staphylococcus aureus (MRSA). She is also currently working on the evaluation of antimicrobial stewardship interventions on antimicrobial utilization and resistance patterns, as well as the evaluation of a hand hygiene compliance program on the transmission of multidrug-resistant organisms.

Research Interests

  • Antimicrobial resistance
  • Hospital epidemiology

Grants

INFECTION PREVENTION IN HOME HEALTH CARE (INHOME) (Federal Gov)

Sep 21 2017 - Jun 30 2021

THE SAFETY OF RED BLOOD CELL TRANSFUSIONS (Federal Gov)

Jul 1 2014 - Dec 31 2018

THE SAFETY OF RED BLOOD CELL TRANSFUSIONS (Federal Gov)

Sep 1 2014 - May 31 2018

THE SAFETY OF RED BLOOD CELL TRANSFUSIONS (Federal Gov)

Sep 1 2014 - May 31 2018

THE SAFETY OF RED BLOOD CELL TRANSFUSIONS (Federal Gov)

Sep 1 2014 - May 31 2018

HEALTH INFORMATION TECHNOLOGY TO REDUCE HEALTHCARE-ASSOCIATED INFECTIONS: HIT-HAI (Federal Gov)

Mar 6 2013 - Dec 31 2016

REDUCINGMULTIDRUG-RESISTANT ORGANISMS (MDRO) AND CLOSTRIDIUM DIFFICILE INFECTIONS (CDI) BY IMPROVING ENVIRONMENTAL CLEANING, ANTIMICROBIAL STEWARDSHIP, AND EDUCATION (REALISE) (NY State Gov)

Apr 1 2013 - Mar 31 2016

PREVENTION OF NOSOCOMIAL INFECTIOUS AND COST-EFFECTIVENESS REFINED (P-NICER) (Federal Gov)

Dec 1 2006 - May 31 2014

MPACT OF AN AUTOMATED SURVEILLANCE SYSTEM ON APPROPRIATED US E OF ISOLATION FOR MRSA (Federal Gov)

Sep 30 2009 - Sep 29 2012

APPLIED RESEARCH IN ANTIMICROBIAL RESISTANCE: STUDIES OF SUS CEPTIBILITY TESTING (Federal Gov)

Sep 30 2007 - Sep 29 2010

Selected Publications

Bernstein DA, Salsgiver E, Simon MS, Greendyke W, Eiras DP, Ito M, Caruso DA, Woodward TM, Perriel OT, Saiman L, Furuya EY, Calfee DP. Understanding Barriers to Optimal Cleaning and Disinfection in Hospitals: A Knowledge, Attitudes, and Practices Survey of Environmental Services Workers. Infect Control Hosp Epidemiol. 2016 Sep 13:1-4. [Epub ahead of print]

Gomez-Simmonds A, Nelson B, Eiras DP, Loo A, Jenkins SG, Whittier S, Calfee DP, Satlin MJ, Kubin CJ, Furuya EY. Combination Regimens for Treatmetn of Carbapenem-Resistant Klebsiella pneumoniae Bloostream Infections. Antimicrob Agents Chemother. 2016 May 23;60(6):3601-7. doi: 10.1128/AAC.03007-15. Print 2016 Jun.

Furuya EY, Dick AW, Herzig CT, Pogorzelska-Maziarz M, Larson EL, Stone PW. Central Line-Associated Bloodstream Infection Reduction and Bundle Compliance in Intensive Care Units: A National Study. Infect Control Hosp Epidemiol. 2016 Jul;37(7):805-10. doi: 10.1017/ice.2016.67. Epub 2016 Apr 7

Edwards JD, Herzig CT, Liu H, Pogorzelska-Maziarz M, Zachariah P, Dick AW, Saiman L, Stone PW, Furuya EY: Central line-associated blood stream infections in pediatric ICUs: Longitudinal trends and compliance with bundle strategies. Am J Infect Control 2015; 43: 489-93.

Vora NM, Kubin CK, Furuya EY: Appropriateness of gram-negative agent use at a tertiary care hospital in the setting of significant antimicrobial resistance. Open Forum Infect Dis 2015. doi: 10.1093/ofid/ofv009

Pogorzelska-Maziarz M, Herzig CT, Larson EL, Furuya EY, Perencevich EN, Stone PW: Implementation of antimicrobial stewardship policies in US hospitals: findings from a national survey. Infect Control Hosp Epidemiol 2015; 36: 261-4.

Nelson BC, Eiras DP, Gomez-Simmonds A, Loo AS, Satlin MJ, Jenkins SG, Whittier S, Calfee DP, Furuya EY, Kubin CJ. Clinical outcomes associated with polymyxin B dose in patients with bloodstream infections due to carbapenem-resistant Gram-negative rods. Antimicrob Agents Chemother. 2015 Nov;59(11):7000-6. doi: 10.1128/AAC.00844-15. Epub 2015 Aug 31

Zachariah P, Furuya EY, Edwards J, Dick A, Liu H, Herzig CT, Pogorzelska-Maziarz M, Stone PW, Saiman L: Compliance with prevention practices and their association with central line-associated bloodstream infections in neonatal intensive care units. Am J Infect Control 2014; 42: 847-851.

Patel SJ, Oliveira AP, Zhou JJ, Alba L, Furuya EY, Weisenberg SA, Jia H, Clock SA, Kubin CJ, Jenkins SG, Schuetz AN, Behta M, Della-Latta P, Whittier S, Rhee K, Saiman L: Risk factors and outcomes of infections caused by extremely drug-resistant gram-negative bacilli in patients hospitalized in intensive care units. Am J Infect Control 2014; 42: 626-631.

Stone PW, Pogorzelska-Maziarz M, Herzig CT, Weiner LM, Furuya EY, Dick A, Larson E: State of infection prevention in US hospitals enrolled in the National Health and Safety Network. Am J Infect Control 2014; 42: 94-99.

Gomez-Simmonds A, Kubin CJ, Furuya EY: Comparison of three severity criteria for Clostridium difficile infection. Infect Control Hosp Epidemiol 2014; 35: 196-199.